ArticleThe Journal of clinical investigation2023

Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression.

Xiaobo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.